Abstract
In this issue of Blood, Shah et al describe the onset of severe acute graft-versus-host disease (GVHD) in 5 of 9 patients who received infusions of ex vivo expanded donor natural killer (NK) cells after HLA-matched hematopoietic stem cell transplantation (HSCT).
MeSH terms
-
4-1BB Ligand / pharmacology*
-
Female
-
Gastrointestinal Neoplasms / therapy*
-
Graft vs Host Disease / pathology*
-
Humans
-
Interleukin-15 / pharmacology*
-
Killer Cells, Natural / transplantation*
-
Male
-
Peripheral Blood Stem Cell Transplantation / methods*
-
Skin Neoplasms / therapy*
Substances
-
4-1BB Ligand
-
IL15 protein, human
-
Interleukin-15